Oncoinvent To Present Initial Safety Data from the Phase 1 T

Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced the presentation of initial safety data from the ongoing Phase 1 clinical trial evaluating the recommended dose, safety and...

Related Keywords

Istanbul , Turkey , Els Van Nieuwenhuysen , European Society Of Gynaecological Oncology , Istanbul Congress Center , Linear Energy Transfer , Product Service , Ovarian Cancer Patients , European Society , Gynaecological Oncology , Experience With Intra Abdominal , Labelled Microparticles , Oral Session , First Experience With Intra Abdominal , Board Number , Current Events , News , Press Release , Echnological News , Omputer News , Cientific News , Usiness News , Health News , Nvironmental News , Sports News , Eisure Activities News , Transportation News , Ravelling News , Ourism News , Ciences , Business , Health , Environment , Sports , Leisure Activities , Ransportation , Travelling , Holidays , Tourism ,